Diabetes & Alzheimer's Diseas

Epidemiological data indicates that a significant portion of the diabetic population exhibits brain changes that are hallmarks of Alzheimer’s disease and vascular dementia. However, direct biological links remain incompletely understood. Here is the latest research.

August 3, 2020

Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport Syndrome

Kidney International
Xiaochen LiuAlessia Fornoni
July 28, 2020
Open Access

Intestinal drug transporters in pathological states: an overview

Pharmacological Reports : PR
Marek DrozdzikAgnieszka Drozdzik
August 6, 2020
Open Access

Zonisamide Ameliorates Cognitive Impairment by Inhibiting ER Stress in a Mouse Model of Type 2 Diabetes Mellitus

Frontiers in Aging Neuroscience
Yong-Xiang HeYing-Hua Liu
August 5, 2020

Burden of Care in Caregivers of Iranian patients with chronic disorders: a systematic review and meta-analysis

Health and Quality of Life Outcomes
Hayedeh RezaeiReza Ghanei Gheshlagh
August 3, 2020

Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease

International Review of Neurobiology
Michael F AlmeidaStephen T Kinsey
August 1, 2020
Open Access

Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions

Frontiers in Neuroscience
Mara DierssenEugenio Barone
July 30, 2020
Open Access

Artificial Intelligence in Health Care: Bibliometric Analysis

Journal of Medical Internet Research
Yuqi GuoFan Yang
July 30, 2020

Brain insulin resistance impairs hippocampal plasticity

Vitamins and Hormones
Matteo SpinelliClaudio Grassi
July 27, 2020
Open Access

The impact of acute rosiglitazone on insulin pharmacokinetics at the blood-brain barrier

Endocrinology, Diabetes & Metabolism
Demi C GalindoElizabeth M Rhea
August 8, 2020

Sensing and modulation of amyloid fibrils by photo-switchable organic dots

Aslam UddinPartha Hazra
July 28, 2020

Circulating Plasma Metabolites and Cognitive Function in a Puerto Rican Cohort

Journal of Alzheimer's Disease : JAD
Natalia PalaciosKatherine L Tucker
July 28, 2020

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing

Nature Reviews. Drug Discovery
Stephen C CunnaneMark J Millan
July 30, 2020

Glibenclamide modulates microglial function and attenuates Aβ deposition in 5XFAD mice

European Journal of Pharmacology
Yeon-Joo JuJong Kil Lee
August 6, 2020
Open Access

Treating Protein Misfolding Diseases: Therapeutic Successes Against Systemic Amyloidoses

Frontiers in Pharmacology
Alice NevoneMario Nuvolone
July 31, 2020

Rebalance the oral microbiota as efficacy tool in endocrine, metabolic, and immune disorders

Endocrine, Metabolic & Immune Disorders Drug Targets
Ciro Gargiulo IsaccoFrancesco Inchingolo

Sign up to follow this feed and discover related papers.

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Antidiabetic Cellular Plasticity

This feed focuses on mechanisms that underlie cellular plasticity as a treatment for diabetes and other degenerative diseases.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.


Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

COVID-19 & Diabetes (ADA)

COVID-19 (short for “Coronavirus Disease 2019") is the disease caused by the novel coronavirus, SARS-CoV-2. Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes. To keep our community as informed as possible, the American Diabetes Association is partnering with the Chan Zuckerberg Initiative's Meta to highlight the latest research developments at the intersection of COVID-19 and diabetes.

© 2020 Meta ULC. All rights reserved